Article Text
Therapeutics
Systematic review and meta-analysis
Intensive statin therapy, compared with moderate dose, increases risk of new onset diabetes but decreases risk of cardiovascular events
Statistics from Altmetric.com
Footnotes
-
Competing interests SNR is an employee of Merck.